Cardiovascular risk factors play greater role in adverse outcomes in thymic cancer patients
Thymic cancer, a rare type of cancer that has brought patients to Indiana University Health in recent years for treatment, has become the subject of further study between investigators from the Krannert Cardiovascular Research Center and the Melvin and Bren Simon Comprehensive Cancer Center at Indiana University School of Medicine, and collaborators at Regenstrief Institute. The researchers wanted to explore cardiovascular risk factors for adverse outcomes among people with and without thymic cancer. Results of their study was published in Frontiers.
MOVE program brightens outlook for breast cancer patients
The Multidisciplinary Oncology Vitality and Exercise (MOVE) Program, developed by oncologist Tarah Ballinger, MD, gives breast cancer patients a personalized plan for exercise and physical
Q&A with Michele Coté, PhD
Michele Coté, PhD, is just getting started in her new role as the second director of the Susan G. Komen Tissue Bank at IU Simon
New research predicts opportunities for increased survival in pancreatic cancer
Pancreatic cancer is relatively rare when compared to other cancers, but still the third leading cause of cancer death in the U.S. with one of
Fighting Fire with Fire: Approaches to Tumor Suppression
IUPUI Researcher publishes promising findings of novel approaches to treating cancer.
Hassanein receives scientific research grant designed to overcome COVID disruptions
Research scientists and those with dependents were significantly impacted by COVID-19 – spending roughly 40 percent less time on studies. To address this challenge, the
Clinician-scientist joins IU Department of Otolaryngology faculty
The Department of Otolaryngology—Head and Neck Surgery at Indiana University School of Medicine has grown significantly over the past three years with the addition of 14 new
Unraveling the Complexities of Cancer Cachexia
The lab of ICMH Member Andrea Bonetto, PhD, investigates the complex and deadly wasting syndrome know as cancer cachexia. Recent breakthroughs have secured external funding
IU School of Medicine professor's mission: End Lung Cancer Now
Nasser Hanna, MD, is spearheading an awareness and advocacy initiative called End Lung Cancer Now to dramatically decrease cancer deaths in Indiana.
Third IU Precision Health Initiative webinar focuses on multiple myeloma progress
The third IU Grand Challenges webinar about the Precision Health Initiative (PHI) took place in October, focusing on progress in studying and treating multiple myeloma,